This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Some COVID-19vaccine manufacturers in the US have refused to share vaccine samples for research purposes , creating an access issue with the potential to delay comparator studies, follow-on research, and new vaccine / drug development. By Aparajita Lath. Duke University, 307 F.3d 3d 1351 (Fed.
As CMIO of Urban Health Plan, a Bronx-based Federally-Qualified Health Center, Connelly-Flores has worked to boost COVID-19vaccination rates via texting campaigns, online vaccine registration and other patient engagement projects focused on one of the areas in the U.S. New York City. hardest hit by the pandemic.
The table arrays data the researchers analyzed from 2002 to 2016, identifying patterns of six types of medical services used by race and age group. Health Populi’s Hot Points: By June 2020, it became clear to the Centers for Disease Control that COVID-19 had been exacting a tougher toll on the lives of people of color in the U.S.
Notice of Enforcement Discretion Regarding Online or Web-Based Scheduling Applications for Scheduling of COVID-19Vaccination Appointments. OCR announced a further Notice of Enforcement Discretion on January 19, 2021, to help HIPAA-covered entities with the rollout of COVID-19vaccines.
So we do have comments on the bizarre complaint that the Texas attorney general recently filed over COVID-19. The complaint, brought under the Texas consumer protection statute, sued a major manufacturer of COVID-19vaccine that was used to control the recent pandemic. 2002); Tracker Marine, L.P.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content